🇺🇸 FDA
Patent

US 12220453

Compositions and treatments for Haemophilus influenzae

granted A61KA61K39/102A61K9/0019

Quick answer

US patent 12220453 (Compositions and treatments for Haemophilus influenzae) held by The Board of Regents of the University of Oklahoma expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K39/102, A61K9/0019, A61P, A61P31/04